Skip to main content
Fig. 5 | Orphanet Journal of Rare Diseases

Fig. 5

From: Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey

Fig. 5

Clinical trial experience according to presenting PKAN phenotype. Respondents were grouped into classic (pink) and atypical (green) PKAN phenotype groups based on their reported age of onset (classic, < 10 years). Respondents who were unable to provide an age of onset were grouped as “not sure” (purple). PKAN = pantothenate kinase-associated neurodegeneration

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172